Royer Biomedical, Inc. is a privately held company based in Frederick, Maryland, specializing in the development of proprietary polymer platform technologies. With a strong research background in polymer chemistry and localized therapeutic systems, Royer holds numerous patents on calcium and gel matrices capable of delivering a wide range of pharmaceutical compounds for various medical fields, including Diabetes, Orthopedics, Cancer, and Infection.
Utilizing their synthetic, animal-free, and collagen-free proprietary platforms, AppliGel VetriGel and Matrix III, Royer Biomedical enables sterile delivery and controlled elution rates, ensuring controlled rates of bioresorption without any immunogenic response, acid production during resorption, or susceptibility to proteolytic enzyme attack.
Generated from the website